Related Experiment Video
Updated: Aug 23, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Cardiac operations in cirrhotic patients
Nobuhiko Hayashida1, Shigeaki Aoyagi
1Department of Surgery, Kurume University School of Medicine, Fukuoka, Japan.
Insights
Cardiac surgery in cirrhosis patients carries high risks due to unique physiological challenges. Minimally invasive techniques may offer safer options for these complex cardiac operations.
Area of Science:
- Cardiology
- Hepatology
- Surgical Oncology
Background:
- Patients with cirrhosis face significantly higher morbidity and mortality rates after cardiac operations involving cardiopulmonary bypass compared to the general population.
- Factors contributing to poor outcomes include compromised nutrition, increased infection risk, and impaired coagulopathy, making cardiac surgery with cardiopulmonary bypass generally contraindicated in advanced cirrhosis.
Purpose of the Study:
- To review the literature on clinical features and outcomes of cardiac surgery in cirrhotic patients.
- To aid cardiac surgeons in determining appropriate therapeutic modalities for this patient group.
- To explore potential improvements in clinical outcomes through better patient selection and postoperative care.
Main Methods:
- Literature review focusing on clinical features and outcomes after cardiac surgery in patients with cirrhosis.
- Analysis of factors influencing postoperative course in cirrhotic patients.
Main Results:
- Cardiac operations with cardiopulmonary bypass are associated with elevated risks in cirrhotic patients.
- Definitive indications for surgical intervention and specific patient selection criteria remain largely unknown.
- Minimally invasive procedures like off-pump coronary artery bypass grafting show promise for safer treatment of advanced cirrhosis patients.
Conclusions:
- Improved understanding of cirrhosis-specific conditions, meticulous patient selection, and intensive postoperative care are crucial for enhancing outcomes.
- Minimally invasive cardiac surgery techniques may represent a safer alternative for cirrhotic patients requiring surgical intervention.
Abstract:
It is well recognized that morbidity and mortality rates after cardiac operations with cardiopulmonary bypass in patients with cirrhosis are significantly higher than those in the general cardiac surgical population. Several contributing factors peculiar to cirrhosis, such as compromised nutritional status, increased susceptibility to infections, and impaired coagulopathy, may be responsible for the poor prognosis. It is empirically agreed that cardiac operations using cardiopulmonary bypass are contraindicated in patients with advanced cirrhosis. However, the population of cirrhotic patients who are referred for cardiac operations is still small and definitive indications for surgical interventions remain unknown. Moreover, cirrhotic patients have many distinctive anatomical and physiological features that influence postoperative course considerably. In this article, we reviewed the literature with special reference to its clinical features and clinical outcomes after cardiac surgery that would help cardiac surgeons to decide therapeutic modality. Further understanding of the unique condition, careful patient selection and intensive postoperative care are required to improve the clinical outcome in cirrhotic patients undergoing cardiopulmonary bypass. Recent developments in minimally invasive procedures, such as off-pump coronary artery bypass grafting, however, may enable us to treat patients with advanced cirrhosis safely.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiac Catheterization I: Pre-Procedure Overview
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Cardiac Catheterization IV: Nursing Management
Heart Failure Drugs: Inotropic Agents
Cardiomyopathy V: Interprofessional Care
